butabindide

butabindide

An agent that was in clinical trials as a possible treatment for obesity. It blocks tripeptidyl peptidase II, an enzyme which metabolises cholecystokinin, restoring appetite in mice. Butabindide reduces the food intake in hungry mice by 45%.